Lorus Therapeutics Inc. · Toronto, ON Canada (Toronto: LOR)
| 2 Meridian Rd. | Phone: +1-416-7981200 |
| Toronto, ON | Fax: +1-416-7982200 |
| M9W 4Z7 | |
| Canada | 
Map This Company |
Lorus Therapeutics Inc. Rankings
Company Description
Lorus Therapeutics isn't talking nonsense, they're talking antisense. The biotechnology firm is developing cancer drugs using antisense technology, which prevents cells from producing disease-causing proteins and may cause fewer side effects than traditional chemotherapies. It is testing its lead candidate in this area, LOR-2040, as a treatment for various blood cancers and solid tumors. Lorus is working in other areas of cancer research as well, developing some traditional therapies, as well as immunotherapies, which stimulate the body's immune system to fight cancer. The company licensed its Virulizin immunotherapy, a potential treatment for pancreatic cancer, to a subsidiary of Zoticon Bioventures in 2008.
Lorus Therapeutics Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Toronto: LOR Headquarters |
|---|---|
| Fiscal Year-End | May |
| 2011 Employees | 17 |
Executives
6 executives listed for Lorus Therapeutics Inc.'s Toronto, ON location.
| Chairman | Dennis Burger | |
|---|---|---|
| Director, President and CEO | Aiping Young | |
| Director Finance and Acting CFO | Elizabeth Williams |